First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

First lead candidate to address a solid tumor indication with significant unmet medical need
Supportive pre-clinical proof of concept data reported at SITC 2023 that demonstrated feasibility,...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Shveta Dighe ,Michael Klichinsky ,Lin Guey ,Moderna Inc ,Nasdaq ,Therapeutics Research Ventures ,Exchange Commission ,Exchange Commission On ,Company Quarterly Report On Form ,Carisma Therapeutics Inc ,Prnewswire Carisma Therapeutics Inc ,Chief Scientific Officer ,Combining Carisma ,Private Securities Litigation Reform Act ,Quarterly Report ,Markets ,